This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Investigations

Authoring team

In a patient suspected of having an acoustic neuroma, the following tests are of value:

  • neuro-otological:
    • pure tone audiometry - demonstrates unilateral sensorineural hearing loss
    • brainstem audiometry - to distinguish cochlear deafness from retrocochlear disease
    • o speech discrimination test (1)
    • caloric test - expect depressed or absent response

  • CT - need contrast since acoustic neuromas are often isodense:
    • intravenous iodinated water soluble contrast (1)
    • metrizemide contrast into the basal cisterns or intrathecal air run up to the cerebellopontine angle clearly identifies small acoustic neuromas

  • MRI - especially for small intracanalicular tumours. With gadolinium - DTPA enhancement, this test is very sensitive and may demonstrate lesions of 1-2 mm in diameter within the auditory canal
    • T2-weighted images
    • contrast enhanced T1-weighted images - the sensitivity is increased by the gadolinium-based contrast medium and it can demonstrate small neuromas and intralbyrinthine lesions (2)

  • tomography of the internal auditor meatus - if no CT/MRI

Reference:

  • (1) British association of otorhinolaryngologists 2002. Clinical effectiveness guidelines, Acoustic neuroma (vestibular schwannoma)
  • (2) Ramnarine Devindra, Whitfield Peter. Management of patients with vestibular schwannoma. ACNR 2005; 5(4).

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.